Laboratoires NEGMA Report issue

For profit Phase 3 Phase 4
Founded: Velizy-villacoublay France (1996)
Status: Acquired by Wockhardt (2007)

Organization Overview

First Clinical Trial
1996
NCT00451360
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 4 Trials (1)

diacerein (4 trials)

Drugs in Phase 3 Trials (1)

art 44 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Inflammation (Phase 4)

Osteoarthritis (Phase 4)

Osteoarthritis, Hip (Phase 3)

Osteoarthritis, Knee (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 2